PHILADELPHIA, USA // June brings more than 20 years of industry experience that spans professional, direct-to-patient, medical education, and managed markets communications. She has motivated and mentored multiple agency teams to produce award-winning work in numerous therapeutic categories — from SSRIs, cardiology, hematology, immunology, hepatology, dermatology vaccines, women’s health, to rare disease.

June has led high-profile launches such as Advair Diskus for Asthma (awarded Launch of the Year by MM&M and Med Ad News), Botox Cosmetic, and Crestor. Direct organic growth included being awarded Advair Diskus for Pediatric Asthma and Advair Diskus for COPD – maintaining all 3 indications for 8 years. Her experience is rounded out with “me-too” products such as Zegerid, and OTC brands that included Aleve, Bayer Aspirin, Flintstones vitamins and Citracal.

Most recently, June led a talented team of creatives on a broad range of local and global Oncology therapies; including Celgene’s Istodax, Polymist, and Revlimid; Taiho Oncology; and Pfizer’s HemeOnc portfolio including Bosulif, Mylotarg, and Besponsa; and Ibrance.

June prides herself on establishing open communication with her clients to maintain fresh insight and relevancy in order to meet immediate and future needs. She has been commended by clients for developing highly motivated creative teams that yield superior and timely results. These teams have been rewarded with just about every major industry award available.